What is the Modified Early Warning Score?
The Modified Early Warning Score emerged in the late 1990s as a refinement to the original Early Warning Score (EWS), designed to streamline bedside assessment across diverse patient populations and clinical settings. Unlike single-parameter monitoring, MEWS integrates multiple physiological variables into one composite score that reflects overall organ system derangement.
The tool gained prominence in acute medicine for its simplicity and predictive value. Variations exist for specialized contexts—the National Early Warning Score (NEWS) standardizes assessment across UK hospitals, while Modified Early Obstetric Warning Score (MEOWS) addresses pregnancy-specific physiology. All versions share the same principle: early detection of deterioration before cascade failure occurs.
MEWS Calculation Method
The MEWS score sums component points derived from six vital sign parameters. Each parameter yields points according to defined ranges; abnormal values (high or low) accumulate higher scores. The formula aggregates these components into a single warning score.
MEWS = Systolic BP points + Heart Rate points + Temperature points + Respiratory Rate points + Urine Output points + AVPU points
Systolic BP— Systolic blood pressure in mmHg; ranges from <70 (3 points) to >199 (3 points), with normal 80–99 scoring 0 pointsHeart Rate— Beats per minute; extremes (>129 or <30) score 3 points, normal 50–99 scores 0 pointsTemperature— Core body temperature in °C; <34°C or >38.9°C scores 3 points, normal 36–37.9°C scores 0 pointsRespiratory Rate— Breaths per minute; <7 or >35 scores 3 points, normal 9–20 scores 0 pointsUrine Output— Millilitres per kilogram of body weight per hour; absence scores 3 points, <0.5 mL/kg/h scores 2 points, normal output scores 0 pointsAVPU— Consciousness level: Alert (0 points), responding to Verbal stimulus (1 point), responding to Pain (2 points), Unresponsive (3 points)
Interpreting MEWS Score Results
MEWS stratifies risk into three broad categories. A score below 3 indicates a stable patient with approximately 7.9% risk of death or ICU admission within 48 hours—routine ward monitoring suffices. Scores of 3–4 suggest early physiological compromise, particularly respiratory insufficiency; these patients warrant closer observation and consideration of higher-level care. A score of 5 or above indicates critical illness with 30% mortality risk and demands immediate senior review and likely ICU or high-dependency unit admission.
The score's strength lies in serial measurement. A rising trend over hours—even within a single category—signals deterioration and should trigger escalation regardless of the absolute number. Conversely, improvement in serial scores reflects positive response to therapy. Context matters: a COVID-19 patient with MEWS <3 but severe respiratory symptoms may still require hospitalization despite the low score.
Clinical Pearls and Common Pitfalls
Avoid these frequent errors when applying MEWS in practice.
- Accurate vital sign measurement — MEWS accuracy depends entirely on correct measurement technique. Use calibrated equipment, allow seated or supine rest before recording blood pressure, and measure core temperature (not peripheral). Erratic results often stem from poor technique rather than true clinical change. Always retake suspicious values.
- Urine output documentation — Urine output calculation requires accurate weight and hourly fluid balance charts. Missing or incomplete records lead to underscoring. In oliguric patients, zero urine output carries maximum weight; document carefully and reassess catheter patency if anuria seems inconsistent with clinical appearance.
- Serial assessment over static values — A single MEWS measurement provides a snapshot; clinical value emerges from trends. A patient with stable score 3 for 6 hours differs greatly from one rising from 2→3→4 over 3 hours. Check MEWS at least 4-hourly in acute settings, more frequently if trending upward or if acute decompensation is suspected.
- AVPU versus Glasgow Coma Scale — MEWS uses the simpler AVPU scale (Alert, Verbal, Pain, Unresponsive) rather than full GCS scoring. Do not conflate them. AVPU is faster for screening but less granular; patients requiring detailed neurological assessment need full GCS documentation alongside MEWS.
When and Why MEWS Matters
MEWS originated to solve a real problem: patients deteriorate gradually, yet busy ward staff sometimes miss early warning signs until crisis point. By anchoring attention to objective numeric thresholds, MEWS reduces cognitive bias and prompts timely escalation. Studies show that systematic early warning scoring reduces unplanned ICU admissions and in-hospital mortality when coupled with clear response protocols.
The tool applies across settings—general wards, emergency departments, post-operative recovery units, and COVID-19 cohorts. Its simplicity makes it teachable to nurses, junior doctors, and allied health staff. However, MEWS is a trigger, not a diagnosis. A high score identifies risk but requires clinical judgment to determine cause and appropriate response. Never treat the score in isolation from the patient's history, examination, and investigations.